NCT02639143View on ClinicalTrials.gov

Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
InflammationThrombosis
Interventions
DRUG

ticagrelor

DRUG

Clopidogrel

All Listed Sponsors
lead

First Affiliated Hospital of Harbin Medical University

OTHER

NCT02639143 - Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI Patients | Biotech Hunter | Biotech Hunter